Search alternatives:
ms decrease » _ decrease (Expand Search), use decreased (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
ms decrease » _ decrease (Expand Search), use decreased (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
37861
-
37862
Can carcinoembryonic antigen replace computed tomography in response evaluation of metastatic colorectal cancer?
Published 2018“…Secondarily, increasing CEA was able to identify all PD patients (sensitivity (Se) = 1.0) and in 50–74% of the patients increasing CEA provided a lead time to PD on upcoming CT. …”
-
37863
Ngn2 and NeuroD1 mark the initiation and end of amplification of hippocampal DG granule neuroblasts, respectively.
Published 2009“…Scale bars: 100 µm (B1, C1 and C2), 50 µm (A1, D1, E1, F1, G1, H1, I1, K and L1), 25 µm (A2, B2, and F2), 10 µm (L2), 5 µm (C3, E2, G2, H2 and I2).…”
-
37864
Effects of static defects and nucleosome rate constant variability on RNAPII density profiles.
Published 2022“…GC content heterogeneity is introduced via Eqs <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009811#pcbi.1009811.e100" target="_blank">49</a> and 50. …”
-
37865
Genome-wide characterization of LTF-responsive viral TSRs.
Published 2021“…LTF-activated TSRs (orange dots) represent TSRs decreasing in strength by more than 50% because of dTag treatment (LTF-activated TSRs). …”
-
37866
Image 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co...
Published 2025“…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
-
37867
DataSheet_1_The presence of silver nanoparticles reduces demand for dissolved phosphorus to the benefit of biological nitrogen fixation in the coastal eastern Mediterranean Sea.pdf
Published 2022“…Three mesocosms were left unamended at ambient light and temperature; three were manipulated with 50 ng AgNPs L<sup>-1</sup>d<sup>-1</sup> and three were amended with 50 ng Ag<sup>+</sup> L<sup>-1</sup>d<sup>-1</sup>. …”
-
37868
Table 1_The germinal center-tertiary lymphoid structure after neoadjuvant chemo-immunotherapy for locally advanced lung squamous cell carcinoma can predict the disease progression....
Published 2025“…</p>Methods<p>The NACT-IO group (72 patients), NACT group (50 patients), UT group (50 patients, un-neoadjuvant therapy) were included. …”
-
37869
Data_Sheet_1_Altered topological properties of functional brain networks in patients with first episode, late-life depression before and after antidepressant treatment.docx
Published 2023“…Objectives<p>To preliminarily explore the functional activity and information integration of the brains under resting state based on graph theory in patients with first-episode, late-life depression (LLD) before and after antidepressant treatment.</p>Methods<p>A total of 50 patients with first-episode LLD and 40 non-depressed controls (NCs) were recruited for the present research. …”
-
37870
Image 5_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co...
Published 2025“…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
-
37871
-
37872
-
37873
-
37874
Table 4_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co...
Published 2025“…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
-
37875
The Red Imported Fire Ant (<i>Solenopsis invicta</i> Buren) Kept Y not F: Predicted sNPY Endogenous Ligands Deorphanize the Short NPF (sNPF) Receptor
Published 2014“…Two <i>S. invicta</i> sNPFs differing at their N-terminus were synthesized that equally activated the sNPFR, SLRSALAAGHLRYa (EC<sub>50</sub> = 3.2 nM) and SALAAGHLRYa (EC<sub>50</sub> = 8.6 nM). …”
-
37876
-
37877
-
37878
Image 1_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co...
Published 2025“…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
-
37879
Image 8_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co...
Published 2025“…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”
-
37880
Image 2_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co...
Published 2025“…The most common AEs in the PC group were blood toxicity related AEs (anemia, neutrophil count decreased, etc).</p>Conclusion<p>The PC therapy continues to provide a substantial survival benefit for patients with stage IIIb-IV NSCLC. …”